Known targets — ChEMBL curated mechanism
SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Phenazopyridine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 1.00 |
| ▸ | MEN1 | O00255 | 8/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 8/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 6/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | HBB | P68871 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.96 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.96 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.96 |
| ▸ | USP2 | O75604 | 1/20 | 0.96 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.96 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.96 |
| ▸ | DRD2 | P14416 | 1/20 | 0.96 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenazopyridine SCHEMBL14687482 | 1.00 | MAPT (1.00) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Phenazopyridine SCHEMBL29392321 | 1.00 | MAPT (1.00) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Phenazopyridine SCHEMBL26499 | 1.00 | MAPT (1.00) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Phenazopyridine SCHEMBL28796595 | 1.00 | MAPT (1.00) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Phenazopyridine SCHEMBL215655 | 1.00 | MAPT (1.00) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Phenazopyridine SCHEMBL301672 | 0.98 | MAPT (0.96) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Phenazopyridine SCHEMBL5973732 | 0.98 | MAPT (0.96) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Phenazopyridine SCHEMBL302506 | 0.98 | MAPT (0.96) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Phenazopyridine SCHEMBL6661856 | 0.98 | MAPT (0.96) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Phenazopyridine SCHEMBL9151827 | 0.98 | MAPT (0.96) | MAPTMEN1KMT2AMAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6736 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617874-B2 | Cyclodextrin-polyoxometalate ionic liquid inclusion complex flame retardant additive for making a low smoke zero halogen compound | CORNING INCORPORATED (US) | 2026-05-05 | — | — | US | claimed |
| US-12486235-B2 | Metal oxide nanoparticle with alkylsiloxane ligands bonded thereto | CUBICPV INC. (US) | 2025-12-02 | — | — | US | claimed |
| US-20250243357-A1 | ULTRA-STRETCHABLE HOP-RING HYDROGELS | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2025-07-31 | — | — | US | claimed |
| CN-119735984-B | Antireflective composition, antireflective film, patterning process, patterned substrate, semiconductor device, and method for manufacturing the same | 珠海基石科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| US-20250134946-A1 | SELF-ASSEMBLING AMPHIPHILIC PEPTIDE HYDROGELS FOR TREATMENT OF NERVE INJURY | GEL4MED, INC. | 2025-05-01 | — | — | US | claimed |
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | nanoSUR LLC | 2025-04-10 | — | — | US | claimed |
| CN-119735984-A | Antireflective composition, antireflective film, patterning process, patterned substrate, semiconductor device, and method for manufacturing the same | 珠海基石科技有限公司 | 2025-04-01 | — | — | CN | claimed |
| US-20250090501-A1 | METHODS OF TREATING GUT MOTILITY DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-03-20 | — | — | US | claimed |
| WO-2025037759-A1 | IONIC ORGANIC FRAMEWORK ELECTROLYTE FOR ALL-SOLID-STATE SECONDARY BATTERY, COMPRISING MULTIPLE COMPONENTS, PREPARATION METHOD THEREFOR, AND ALL-SOLID-STATE SECONDARY BATTERY COMPRISING SAME | 한양대학교 에리카산학협력단 | 2025-02-20 | — | — | WO | claimed |
| US-RE50250-E1 | Process for the preparation of cis-alpha,beta substituted cyclopentanones | FIRMENICH SA (CH) | 2024-12-31 | — | — | US | claimed |
| EP-0353474-A2 | Glycerin derivative and its pharmacological use | Eisai Co., Ltd. (JP) | 1990-02-07 | — | — | EP | claimed |
| EP-0313684-A1 | Solution for eliminating intra-abdominal infections | GENECO, INC. (US) | 1989-05-03 | — | — | EP | claimed |
| US-4704102-A | Method of eliminating intra abdominal infections | GENECO INC. (US) | 1987-11-03 | — | — | US | claimed |
| US-4544615-A | POLYACETYLENE, POLYPYRROLES, AROMATIC RESINS | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1985-10-01 | — | — | US | claimed |
| EP-0034228-B1 | REFORMING PROCESS | MOBIL OIL CORPORATION (US) | 1984-10-10 | — | — | EP | claimed |
| US-4455147-A | COLORING TEXTILES, ANIONIC AND CATIONIC SURFACTANTS | I.W.S. NOMINEE COMPANY, LIMITED (GB) | 1984-06-19 | — | — | US | claimed |
| EP-0005569-B1 | RESIN-LIGAND-TRANSITION METAL COMPLEX COMPOSITION AND PROCESSES FOR USING THIS COMPOSITION AS CATALYST | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1981-11-04 | — | — | EP | claimed |
| US-4226863-A | BACTERICIDES, ANTIBIOTICS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-10-07 | — | — | US | claimed |
| US-4056609-A | Article for diagnosis of achlorhydria | GUNN, KIRCHUBEL & MILLER (US) | 1977-11-01 | — | — | US | claimed |
| US-4017501-A | Process for preparing pyridinium chloride salts of alkyl esters of 2-chloro-N-2-hydroxyethylacetamide | AMERICAN CYANAMID COMPANY (US) | 1977-04-12 | — | — | US | claimed |